Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 27 June 1997:
Vol. 276. no. 5321, pp. 2048 - 2050
DOI: 10.1126/science.276.5321.2048
Prev | Table of Contents | Next

Reports

Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ1 Opioid Receptor Mechanism

Gianluigi Tanda, Francesco E. Pontieri, * Gaetano Di Chiara dagger

The effects of the active ingredient of Cannabis, Delta 9-tetrahydrocannabinol (Delta 9-THC), and of the highly addictive drug heroin on in vivo dopamine transmission in the nucleus accumbens were compared in Sprague-Dawley rats by brain microdialysis. Delta 9-THC and heroin increased extracellular dopamine concentrations selectively in the shell of the nucleus accumbens; these effects were mimicked by the synthetic cannabinoid agonist WIN55212-2. SR141716A, an antagonist of central cannabinoid receptors, prevented the effects of Delta 9-THC but not those of heroin. Naloxone, a generic opioid antagonist, administered systemically, or naloxonazine, an antagonist of µ1 opioid receptors, infused into the ventral tegmentum, prevented the action of cannabinoids and heroin on dopamine transmission. Thus, Delta 9-THC and heroin exert similar effects on mesolimbic dopamine transmission through a common µ1 opioid receptor mechanism located in the ventral mesencephalic tegmentum.

Department of Toxicology and Consiglio Nazionale delle Ricerche (CNR), Center for Neuropharmacology, University of Cagliari, Viale A. Diaz 182, 09126 Cagliari, Italy.
*   Present address: Department of Neuroscience, University "La Sapienza," Viale dell'Università 30, 00185 Roma, Italy.

dagger    To whom correspondence should be addressed.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway.
O. D. Howes and S. Kapur (2009)
Schizophr Bull 35, 549-562
   Abstract »    Full Text »    PDF »
Modulation of Mediotemporal and Ventrostriatal Function in Humans by {Delta}9-Tetrahydrocannabinol: A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis.
S. Bhattacharyya, P. Fusar-Poli, S. Borgwardt, R. Martin-Santos, C. Nosarti, C. O'Carroll, P. Allen, M. L. Seal, P. C. Fletcher, J. A. Crippa, et al. (2009)
Arch Gen Psychiatry 66, 442-451
   Abstract »    Full Text »    PDF »
Childhood Sexual Abuse, Early Cannabis Use, and Psychosis: Testing an Interaction Model Based on the National Comorbidity Survey.
J. E. Houston, J. Murphy, G. Adamson, M. Stringer, and M. Shevlin (2008)
Schizophr Bull 34, 580-585
   Abstract »    Full Text »    PDF »
Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors.
M. Canals and G. Milligan (2008)
J. Biol. Chem. 283, 11424-11434
   Abstract »    Full Text »    PDF »
Glutamate Release in the Nucleus Accumbens Core Is Necessary for Heroin Seeking.
R. T. LaLumiere and P. W. Kalivas (2008)
J. Neurosci. 28, 3170-3177
   Abstract »    Full Text »    PDF »
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants.
A.-G. Corbille, E. Valjent, G. Marsicano, C. Ledent, B. Lutz, D. Herve, and J.-A. Girault (2007)
J. Neurosci. 27, 6937-6947
   Abstract »    Full Text »    PDF »
Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects.
M. Bifulco, C. Grimaldi, P. Gazzerro, S. Pisanti, and A. Santoro (2007)
Mol. Pharmacol. 71, 1445-1456
   Abstract »    Full Text »    PDF »
Nicotinic {alpha}7 Receptors as a New Target for Treatment of Cannabis Abuse.
M. Solinas, M. Scherma, L. Fattore, J. Stroik, C. Wertheim, G. Tanda, W. Fratta, and S. R. Goldberg (2007)
J. Neurosci. 27, 5615-5620
   Abstract »    Full Text »    PDF »
Cannabinoid CB1 Receptor Antagonist AM251 Inhibits Cocaine-Primed Relapse in Rats: Role of Glutamate in the Nucleus Accumbens..
Z.-X. Xi, J. G. Gilbert, X.-Q. Peng, A. C. Pak, X. Li, and E. L. Gardner (2006)
J. Neurosci. 26, 8531-8536
   Abstract »    Full Text »    PDF »
Effects of 4'-Chloro-3{alpha}-(diphenylmethoxy)-tropane on Mesostriatal, Mesocortical, and Mesolimbic Dopamine Transmission: Comparison with Effects of Cocaine.
G. Tanda, A. Ebbs, A. H. Newman, and J. L. Katz (2005)
J. Pharmacol. Exp. Ther. 313, 613-620
   Abstract »    Full Text »    PDF »
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence.
B. Le Foll and S. R. Goldberg (2005)
J. Pharmacol. Exp. Ther. 312, 875-883
   Abstract »    Full Text »    PDF »
ROLE OF THE ENDOCANNABINOID SYSTEM IN THE DEVELOPMENT OF TOLERANCE TO ALCOHOL.
B. S. BASAVARAJAPPA and B. L. HUNGUND (2005)
Alcohol Alcohol. 40, 15-24
   Abstract »    Full Text »    PDF »
Legalization of Marijuana: Potential Impact on Youth.
A. Joffe, W. S. Yancy, and the Committee on Substance Abuse and Committee on (2004)
Pediatrics 113, e632-e638
   Abstract »    Full Text »
Cannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats.
J. F. Cheer, K. M. Wassum, M. L. A. V. Heien, P. E. M. Phillips, and R. M. Wightman (2004)
J. Neurosci. 24, 4393-4400
   Abstract »    Full Text »    PDF »
Chronic Cannabis Abuse Raises Nerve Growth Factor Serum Concentrations in Drug-Naive Schizophrenic Patients.
M. C. Jockers-ScheruBl, U. Matthies, H. Danker-Hopfe, U. E. Lang, R. Mahlberg, and R. Hellweg (2003)
J Psychopharmacol 17, 439-445
   Abstract »    PDF »
Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus: Site and Mechanism of Action.
E. T. Tzavara, M. Wade, and G. G. Nomikos (2003)
J. Neurosci. 23, 9374-9384
   Abstract »    Full Text »    PDF »
Cannabis and the brain.
L. Iversen (2003)
Brain 126, 1252-1270
   Abstract »    Full Text »    PDF »
Microbial Infections, Immunomodulation, and Drugs of Abuse.
H. Friedman, C. Newton, and T. W. Klein (2003)
Clin. Microbiol. Rev. 16, 209-219
   Abstract »    Full Text »    PDF »
The effect of anandamide on prolactin secretion is modulated by estrogen.
C. Scorticati, C. Mohn, A. De Laurentiis, P. Vissio, J. Fernandez Solari, A. Seilicovich, S. M. McCann, and V. Rettori (2003)
PNAS 100, 2134-2139
   Abstract »    Full Text »    PDF »
Escalation of Drug Use in Early-Onset Cannabis Users vs Co-twin Controls.
M. T. Lynskey, A. C. Heath, K. K. Bucholz, W. S. Slutske, P. A. F. Madden, E. C. Nelson, D. J. Statham, and N. G. Martin (2003)
JAMA 289, 427-433
   Abstract »    Full Text »    PDF »
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.
S. Zammit, P. Allebeck, S. Andreasson, I. Lundberg, and G. Lewis (2002)
BMJ 325, 1199
   Abstract »    Full Text »    PDF »
The Longitudinal Relationship Between Drug Use and Risky Sexual Behaviors Among Colombian Adolescents.
D. W. Brook, J. S. Brook, T. Pahl, and I. Montoya (2002)
Arch Pediatr Adolesc Med 156, 1101-1107
   Abstract »    Full Text »    PDF »
Cannabis Use and Psychosis: A Longitudinal Population-based Study.
J. van Os, M. Bak, M. Hanssen, R. V. Bijl, R. de Graaf, and H. Verdoux (2002)
Am. J. Epidemiol. 156, 319-327
   Abstract »    Full Text »    PDF »
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens.
D. Robbe, M. Kopf, A. Remaury, J. Bockaert, and O. J. Manzoni (2002)
PNAS 99, 8384-8388
   Abstract »    Full Text »    PDF »
A missense mutation in human fatty acid amide hydrolase associated with problem drug use.
J. C. Sipe, K. Chiang, A. L. Gerber, E. Beutler, and B. F. Cravatt (2002)
PNAS 99, 8394-8399
   Abstract »    Full Text »    PDF »
Differential Expression of Motivational Stimulus Properties by Dopamine in Nucleus Accumbens Shell versus Core and Prefrontal Cortex.
V. Bassareo, M. A. De Luca, and G. Di Chiara (2002)
J. Neurosci. 22, 4709-4719
   Abstract »    Full Text »    PDF »
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors.
A. C. Howlett, F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, et al. (2002)
Pharmacol. Rev. 54, 161-202
   Abstract »    Full Text »    PDF »
Cannabinoid Addiction: Behavioral Models and Neural Correlates.
R. Maldonado and F. Rodriguez de Fonseca (2002)
J. Neurosci. 22, 3326-3331
   Abstract »    Full Text »    PDF »
Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review.
U. Shalev, J. W. Grimm, and Y. Shaham (2002)
Pharmacol. Rev. 54, 1-42
   Abstract »    Full Text »    PDF »
Clinical Evaluation of Substance Abuse.
P. Kaul and S. M. Coupey (2002)
Pediatr. Rev. 23, 85-94
   Full Text »    PDF »
Motivational Effects of Cannabinoids Are Mediated by {micro}-Opioid and kappa -Opioid Receptors.
S. Ghozland, H. W. D. Matthes, F. Simonin, D. Filliol, B. L. Kieffer, and R. Maldonado (2002)
J. Neurosci. 22, 1146-1154
   Abstract »    Full Text »    PDF »
Prevention of Cannabinoid Withdrawal Syndrome by Lithium: Involvement of Oxytocinergic Neuronal Activation.
S.-S. Cui, R. C. Bowen, G.-B. Gu, D. K. Hannesson, P. H. Yu, and X. Zhang (2001)
J. Neurosci. 21, 9867-9876
   Abstract »    Full Text »    PDF »
Absence of Delta -9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice.
A. Zimmer, E. Valjent, M. Konig, A. M. Zimmer, P. Robledo, H. Hahn, O. Valverde, and R. Maldonado (2001)
J. Neurosci. 21, 9499-9505
   Abstract »    Full Text »    PDF »
Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission.
I. Katona, E. A. Rancz, L. Acsady, C. Ledent, K. Mackie, N. Hajos, and T. F. Freund (2001)
J. Neurosci. 21, 9506-9518
   Abstract »    Full Text »    PDF »
Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-Administration.
M. Navarro, M. R. A. Carrera, W. Fratta, O. Valverde, G. Cossu, L. Fattore, J. A. Chowen, R. Gomez, I. del Arco, M. A. Villanua, et al. (2001)
J. Neurosci. 21, 5344-5350
   Abstract »    Full Text »    PDF »
Hibernation, a Model of Neuroprotection.
F. Zhou, X. Zhu, R. J. Castellani, R. Stimmelmayr, G. Perry, M. A. Smith, and K. L. Drew (2001)
Am. J. Pathol. 158, 2145-2151
   Abstract »    Full Text »    PDF »
Sexual Behavior Induction of c-Fos in the Nucleus Accumbens and Amphetamine-Stimulated Locomotor Activity Are Sensitized by Previous Sexual Experience in Female Syrian Hamsters.
K. C. Bradley and R. L. Meisel (2001)
J. Neurosci. 21, 2123-2130
   Abstract »    Full Text »    PDF »
Pharmacology and effects of cannabis: a brief review.
C. H. ASHTON (2001)
The British Journal of Psychiatry 178, 101-106
   Abstract »    Full Text »    PDF »
Progesterone receptor and dopamine receptors are required in Delta 9-tetrahydrocannabinol modulation of sexual receptivity in female rats.
S. K. Mani, A. Mitchell, and B. W. O'Malley (2001)
PNAS
   Abstract »    Full Text »
Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens.
D. Robbe, G. Alonso, F. Duchamp, J. Bockaert, and O. J. Manzoni (2001)
J. Neurosci. 21, 109-116
   Abstract »    Full Text »    PDF »
Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice.
O. Valverde, R. Maldonado, E. Valjent, A. M. Zimmer, and A. Zimmer (2000)
J. Neurosci. 20, 9284-9289
   Abstract »    Full Text »    PDF »
Dissociation in Conditioned Dopamine Release in the Nucleus Accumbens Core and Shell in Response to Cocaine Cues and during Cocaine-Seeking Behavior in Rats.
R. Ito, J. W. Dalley, S. R. Howes, T. W. Robbins, and B. J. Everitt (2000)
J. Neurosci. 20, 7489-7495
   Abstract »    Full Text »    PDF »
Mechanisms of Cannabinoid Inhibition of GABAA Synaptic Transmission in the Hippocampus.
A. F. Hoffman and C. R. Lupica (2000)
J. Neurosci. 20, 2470-2479
   Abstract »    Full Text »    PDF »
Differential Superactivation of Adenylyl Cyclase Isozymes after Chronic Activation of the CB1 Cannabinoid Receptor.
M.-H. Rhee, I. Nevo, T. Avidor-Reiss, R. Levy, and Z. Vogel (2000)
Mol. Pharmacol. 57, 746-752
   Abstract »    Full Text »
D2, but Not D1 Dopamine Receptor Agonists Potentiate Cannabinoid-Induced Sedation in Nonhuman Primates.
J. P. Meschler, F. A. Clarkson, P. J. Mathews, A. C. Howlett, and B. K. Madras (2000)
J. Pharmacol. Exp. Ther. 292, 952-959
   Abstract »    Full Text »
Substance Abuse, Neurobiology, and Ideology.
J. C. M. Brust (1999)
Arch Neurol 56, 1528-1531
   Full Text »    PDF »
Marijuana: A Continuing Concern for Pediatricians.
Committee on Substance Abuse (1999)
Pediatrics 104, 982-985
   Abstract »    Full Text »
Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures.
T. Nagayama, A. D. Sinor, R. P. Simon, J. Chen, S. H. Graham, K. Jin, and D. A. Greenberg (1999)
J. Neurosci. 19, 2987-2995
   Abstract »    Full Text »    PDF »
Dissociation in Effects of Lesions of the Nucleus Accumbens Core and Shell on Appetitive Pavlovian Approach Behavior and the Potentiation of Conditioned Reinforcement and Locomotor Activity by D-Amphetamine.
J. A. Parkinson, M. C. Olmstead, L. H. Burns, T. W. Robbins, and B. J. Everitt (1999)
J. Neurosci. 19, 2401-2411
   Abstract »    Full Text »    PDF »
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use.
B. B. Fredholm, K. Battig, J. Holmen, A. Nehlig, and E. E. Zvartau (1999)
Pharmacol. Rev. 51, 83-133
   Abstract »    Full Text »    PDF »
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice.
C. Ledent, O. Valverde, G. Cossu, F. Petitet, J. Aubert, F. Beslot, G. A. Böhme, A. Imperato, T. Pedrazzini, B. P. Roques, et al. (1999)
Science 283, 401-404
   Abstract »    Full Text »
Co-occurrence of Abuse of Different Drugs in Men: The Role of Drug-Specific and Shared Vulnerabilities.
M. T. Tsuang, M. J. Lyons, J. M. Meyer, T. Doyle, S. A. Eisen, J. Goldberg, W. True, N. Lin, R. Toomey, and L. Eaves (1998)
Arch Gen Psychiatry 55, 967-972
   Abstract »    Full Text »    PDF »
Cannabis Use, Abuse, and Dependence in a Population-Based Sample of Female Twins.
K. S. Kendler and C. A. Prescott (1998)
Am J Psychiatry 155, 1016-1022
   Abstract »    Full Text »
Research in Addiction: An Update.
H. G. Pope Jr. (1998)
Am J Psychiatry 155, 304--305
   Full Text »
Drug Abuse: Hedonic Homeostatic Dysregulation.
G. F. Koob and M. L. Moal (1997)
Science 278, 52-58
   Abstract »    Full Text »
Psychoactive Drug Use in Evolutionary Perspective.
R. M. Nesse and K. C. Berridge (1997)
Science 278, 63-66
   Abstract »    Full Text »
Marijuana: More Dangerous Than We Thought?.
(1997)
Journal Watch Dermatology 1997, 13
   Full Text »
MARIJUANA: MORE DANGEROUS THAN WE THOUGHT?.
(1997)
Journal Watch (General) 1997, 8
   Full Text »
From the Cover: Progesterone receptor and dopamine receptors are required in Delta 9-tetrahydrocannabinol modulation of sexual receptivity in female rats.
S. K. Mani, A. Mitchell, and B. W. O'Malley (2001)
PNAS 98, 1249-1254
   Abstract »    Full Text »    PDF »
Stimulation of In Vivo Dopamine Transmission in the Bed Nucleus of Stria Terminalis by Reinforcing Drugs.
E. Carboni, A. Silvagni, M. T. P. Rolando, and G. Di Chiara (2000)
J. Neurosci. 20, RC102
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)